Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP

Abroad (travel likely)RecruitingPHASE4

Conditions

Hiv · Opioid Use Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

APT Foundation, New Haven, Connecticut, United States
Contact: Study coordinator (Brian Sibilio, BS) · brian.sibilio@uconn.edu · 2037814690

Study leads

Michael Copenhaver, PhD
Principal Investigator
University of Connecticut

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

HIV-1-infection

Abroad (travel likely)RecruitingPHASE4

Buenos Aires, Argentina · Panama City, Panama

HIV Prevention and Care Interventions for Youth in Uganda

HIV

Abroad (travel likely)RecruitingPHASE4

Kampala, Uganda

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

Human Immunodeficiency Virus (HIV) · HIV Pre-Exposure Prophylaxis

Abroad (travel likely)RecruitingPHASE3

Homabay County, Kenya · Thika, Kenya

Intervention to Improve Parent Communication About Sexuality

HIV/STI Incidence · Communication About Health Information

Abroad (travel likely)Recruiting

Philadelphia, United States